RXST as of Nov 2 · 12:40 ET
RXSTNasdaqOphthalmic Goods
RxSight, Inc. · Brief
Next report
2 days
Nov 4 · after closeest.Q3 FY26
Expected move
No implied move.
1 of 7≥ implied
- avg implied
- ±33.9%
- avg realized
- ±11.0%
Jul 8 '25±11.3%▼−37.84%×3.35
Aug 7 '25±13.4%▼−7.70%×0.57
Nov 5 '25±57.1%▲+3.24%×0.06
Jan 12 '26±16.4%▲+0.20%×0.01
Q1 FY26±25.6%▼−10.10%×0.39
May 6 '26±62.1%▼−14.45%×0.23
Q2 FY26—▲+0.36%—
Aug 5 '26±51.3%▼−3.34%×0.07
quarterimplied−65%0+65%realized×
Aug '26±51.3%▼−3.34%×0.07
Q2 FY26—▲+0.36%—
May '26±62.1%▼−14.45%×0.23
Q1 FY26±25.6%▼−10.10%×0.39
Jan '26±16.4%▲+0.20%×0.01
Nov '25±57.1%▲+3.24%×0.06
2 older reports
Aug '25±13.4%▼−7.70%×0.57
Jul '25±11.3%▼−37.84%×3.35
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 4 report · est.Bull2
+29.43%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
Bear2
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
RXST report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.